Noah Goodman Insider Trades & Stock Holdings

Chief Business Officer · Kymera Therapeutics, Inc. · Latest filing Jun 25, 2026

Noah Goodman, Chief Business Officer at Kymera Therapeutics, Inc. has 4 Form 4 trades on file since Jun 22, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($817.50K), net -$817.50K. Latest filing: disposed of 5K shares of $KYMR on Jun 25, 2026 at $114.

Trades on file

4

Open-market bought

$0

Open-market sold

$817.50K

Net open-market

-$817.50K

Latest filing

Jun 25, 2026

All insider trades by Noah Goodman

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 25, 2026	$KYMR	Sell (Open-market sale) 10b5-1	5K	$114	$570K			-2.5%	-5.5%		Chief Business Officer		—
Jun 25, 2026	$KYMR	Buy (Option exercise)	5K	$21.05	$105.25K			-2.5%	-5.5%		Chief Business Officer		—
Jun 22, 2026	$KYMR	Sell (Open-market sale) 10b5-1	2.50K	$99	$247.50K			+9.9%	+11.0%		Chief Business Officer		—
Jun 22, 2026	$KYMR	Buy (Option exercise)	2.50K	$21.05	$52.62K			+9.9%	+11.0%		Chief Business Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Noah Goodman traded

• $KYMR

Frequently asked questions

Has Noah Goodman been buying or selling stock?

Noah Goodman has 0 open-market purchases and 2 open-market sales on file, net -$817.50K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Noah Goodman's latest insider trade?

disposed of 5K shares of $KYMR on Jun 25, 2026 at $114.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.